Cibc Asset Management Inc Johnson & Johnson Transaction History

Cibc Asset Management Inc

$25.9 Billion
Q2 2024

A detailed history of Cibc Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Cibc Asset Management Inc holds 601,268 shares of JNJ stock, worth $99.5 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

601,268

Previous 827,167 27.31%

Holding current value

$99.5 Million

Previous $131 Million 32.84%

% of portfolio

0.34%

Previous 0.49%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$144.38 - $157.78 $32.6 Million - $35.6 Million	-225,899 Reduced 27.31%	601,268 $87.9 Million
Q1 2024 May 09, 2024	SELL	$155.22 - $162.74 $20.5 Million - $21.5 Million	-132,389 Reduced 13.8%	827,167 $131 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $31.9 Million - $34.9 Million	-219,436 Reduced 18.61%	959,556 $150 Million
Q3 2023 Oct 30, 2023	SELL	$155.75 - $174.48 $16 Million - $17.9 Million	-102,537 Reduced 8.0%	1,178,992 $184 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $12.5 Million - $13.5 Million	-80,979 Reduced 5.94%	1,281,529 $212 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $10.3 Million - $12.3 Million	68,244 Added 5.27%	1,362,508 $211 Million
Q4 2022 Feb 13, 2023	BUY	$160.2 - $179.79 $1.59 Million - $1.78 Million	9,921 Added 0.77%	1,294,264 $229 Million
Q3 2022 Nov 03, 2022	BUY	$161.33 - $179.52 $77 Million - $85.6 Million	477,016 Added 59.09%	1,284,343 $210 Million
Q2 2022 Aug 09, 2022	BUY	$168.19 - $186.01 $72.3 Million - $79.9 Million	429,666 Added 113.77%	807,327 $143 Million
Q1 2022 May 06, 2022	BUY	$158.14 - $179.59 $4.12 Million - $4.67 Million	26,026 Added 7.4%	377,661 $66.9 Million
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $1.85 Million - $2.05 Million	11,870 Added 3.49%	351,635 $60.2 Million
Q3 2021 Nov 09, 2021	BUY	$161.5 - $179.47 $1.31 Million - $1.46 Million	8,120 Added 2.45%	339,765 $54.9 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $2.38 Million - $2.55 Million	-14,900 Reduced 4.3%	331,645 $54.6 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $1.02 Million - $1.13 Million	-6,640 Reduced 1.88%	346,545 $57 Million
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $1.42 Million - $1.63 Million	10,367 Added 3.02%	353,185 $55.6 Million
Q3 2020 Nov 05, 2020	BUY	$140.38 - $153.83 $2.43 Million - $2.66 Million	17,318 Added 5.32%	342,818 $51 Million
Q2 2020 Jul 28, 2020	BUY	$128.81 - $155.51 $7.18 Million - $8.67 Million	55,729 Added 20.66%	325,500 $45.8 Million
Q1 2020 Apr 30, 2020	SELL	$111.14 - $153.99 $409,217 - $566,991	-3,682 Reduced 1.35%	269,771 $35.4 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $936,742 - $1.08 Million	7,347 Added 2.76%	273,453 $39.9 Million
Q3 2019 Oct 30, 2019	SELL	$126.95 - $142.14 $537,252 - $601,536	-4,232 Reduced 1.57%	266,106 $34.4 Million
Q2 2019 Aug 05, 2019	SELL	$131.15 - $144.24 $1.59 Million - $1.75 Million	-12,120 Reduced 4.29%	270,338 $37.7 Million
Q1 2019 May 06, 2019	BUY	$125.72 - $139.79 $2.23 Million - $2.48 Million	17,758 Added 6.71%	282,458 $39.5 Million
Q4 2018 Feb 12, 2019	SELL	$122.84 - $147.84 $906,804 - $1.09 Million	-7,382 Reduced 2.71%	264,700 $34.2 Million
Q3 2018 Nov 02, 2018	BUY	$121.58 - $142.88 $97,507 - $114,589	802 Added 0.3%	272,082 $37.6 Million
Q2 2018 Aug 09, 2018	SELL	$119.4 - $131.76 $6.13 Million - $6.76 Million	-51,336 Reduced 15.91%	271,280 $32.9 Million
Q1 2018 Apr 30, 2018	SELL	$125.1 - $148.14 $6.59 Million - $7.81 Million	-52,715 Reduced 14.04%	322,616 $41.3 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $3.07 Million - $3.36 Million	-23,394 Reduced 5.87%	375,331 $52.4 Million
Q3 2017 Nov 06, 2017	BUY	$129.47 - $135.38 $51.6 Million - $54 Million	398,725	398,725 $51.8 Million

Others Institutions Holding JNJ

# of Institutions

4,160

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $433B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Johnson & Johnson Transaction History